This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Stratagene expects its partnerships for molecular diagnostics and pharmacogenomics will result in new instrument launches in 2007 and 2008, and hopes that the reinstatement of a key patent will provide it with leverage in negotiations with rivals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.